Market research
MEDS DataMEDS AI, Inc.
NASDAQ USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the MEDS discussion.
5 years, 4 months ago
Trxade Group, Inc is currently in a long term uptrend where the price is trading 6.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.
Trxade Group, Inc's total revenue rose by 17.6% to $2M since the same quarter in the previous year.
Its net income has increased by 145.2% to $224K since the same quarter in the previous year.
Finally, its free cash flow grew by 99.7% to $-788 since the same quarter in the previous year.
Based on the above factors, Trxade Group, Inc gets an overall score of 5/5.